Similar articles

• Eculizumab Modifies Outcomes in Adults with Atypical Hemolytic Uremic Syndrome with Acute Kidney Injury.

  Cao M, Leite BN, Ferreiro T, Calvo M, Fernández C, Alonso Á, Rodriguez A, Salvador P, Seijo R, Pita S, Arjona E, Rodríguez de Córdoba S, Valdés Cañedo F. Cao M, et al. Am J Nephrol. 2018;48(3):225-233. doi: 10.1159/000492865. Epub 2018 Sep 11. Am J Nephrol. 2018. PMID: 30205388
• [Recurrent atypical hemolytic uremic syndrome after renal transplantation: treatment with eculizumab].

  Latzke AB, Fernández P, Chiurchiu C, Sarmantano D, De Arteaga J, Douthat W, De la Fuente J. Latzke AB, et al. Medicina (B Aires). 2018;78(2):119-122. Medicina (B Aires). 2018. PMID: 29659362 Spanish.
• Bevacizumab-induced atypical hemolytic uremic syndrome and treatment with eculizumab.

  Vakiti A, Singh D, Pilla R, Alhaj-Moustafa M, Fitzpatrick KW. Vakiti A, et al. J Oncol Pharm Pract. 2019 Jun;25(4):1011-1015. doi: 10.1177/1078155218774895. Epub 2018 May 17. J Oncol Pharm Pract. 2019. PMID: 29768958
• Complement activation in atypical hemolytic uremic syndrome and scleroderma renal crisis: a critical analysis of pathophysiology.

  Zuckerman R, Asif A, Costanzo EJ, Vachharajani T. Zuckerman R, et al. J Bras Nefrol. 2018 Jan-Mar;40(1):77-81. doi: 10.1590/2175-8239-JBN-3807. Epub 2018 May 7. J Bras Nefrol. 2018. PMID: 29796581 Free PMC article. Review.
• [HELLP syndrome and hemolytic uremic syndrome during pregnancy: two disease entities, same causation. Case report and literature review].

  Mancini A, Ardissino G, Angelini P, Giancaspro V, La Raia E, Nisi M, Proscia A, Tarantino G, Vitale O, D'elia F. Mancini A, et al. G Ital Nefrol. 2019 Apr;36(2):2019-vol2. G Ital Nefrol. 2019. PMID: 30983177 Review. Italian.